Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1625 of 6351
-
New drug cocktail takes on advanced lung cancer in first human trial
Disease control Recruiting nowThis is a first-in-human, open-label, multicenter Phase I/II study of MHB036C combined with MHB039A or other anti-tumor therapy in patients with advanced lung cancer. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of M…
Phase 1/2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Liquid plug could stop bleeding without surgery
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.
Sponsor: Medtronic Endovascular • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a laser measure gut lesions better than the human eye?
Knowledge-focused Recruiting nowThe goal of this prospective observational study is to assess the accuracy and reliability of laser readings obtained through AccuMeasure, in comparison to other measurements performed by gastroenterologists. AccuMeasure is a novel technology, that has emerged as a promising tool…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Could a simple knee injection ease arthritis pain?
Disease control Ongoing53-Week Study Evaluating the Safety and Efficacy of Intra-articular (IA) Injections of TPX-100 vs Placebo in Subjects with Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
Phase 2 • Sponsor: OrthoTrophix, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
AI blood test could spot lung cancer return earlier
Knowledge-focused Recruiting nowThis project aims to innovatively integrate multi-omics data, including plasma metabolomics, radiomics, and cfDNA multi-level information, combined with survival data (e.g., RFS), to establish a novel multidimensional approach for noninvasive postoperative recurrence monitoring i…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Could a forehead device stop seizures in veterans?
Disease control OngoingBackground: Epilepsy is a common neurological disorder among veterans. Medications do not control seizures in 1/3rd of patients, who often require neurostimulation. However, current neurostimulation devices are invasive. Objective: The investigators propose a novel clinical trial…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug MB0151 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis is a multicenter, open-label, single-arm, dose-escalation and dose-expansion Phase I/II study to evaluate the safety, tolerability and preliminary anti-tumor activity of MB0151 in adult subjects (at least 18 years old) with advanced solid tumors. This study includes two phas…
Phase 1/2 • Sponsor: Mainline Biosciences (Shanghai) Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Immune cell booster shows promise for Hard-to-Treat cancers
Disease control OngoingThis study is a single-center, prospective, Phase Ib/II clinical trial designed to evaluate the safety and efficacy of cell membrane-modified memory NK cells in treating patients with advanced metastatic solid tumors. The primary objective of this study is to evaluate the safety…
Phase 1/2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study tests app and group classes to keep Seniors' minds sharp
Prevention By invitation onlySingapore's rising dementia incidence with an ageing population presents an urgent need for effective interventions that delay or prevent cognitive decline. While multi-domain intervention studies for dementia prevention show promise, there is a need for an effective personalised…
Sponsor: Tan Tock Seng Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
Personalized vaccine takes on head and neck cancer in early trial
Disease control Recruiting nowThis phase Ib trial tests the safety, side effects and best dose of tumor membrane vesicle (TMV) vaccine therapy alone and in combination with pembrolizumab and evaluates how well it works in treating patients with head and neck squamous cell cancer that has come back after a per…
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Talking therapy may cool hot flushes for NHS workers
Symptom relief CompletedThe goal of this feasibility study/clinical trial is to evaluate the feasibility and acceptability of a CBT group programme (MENOS protocol) for hot flushes and night sweats for National Health Service (in The United Kingdom) healthcare workers experiencing difficult menopause sy…
Sponsor: Queen's University, Belfast • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a simple antibody infusion shield myeloma patients from infections?
Disease control Recruiting nowThe main purpose of this study is to see if IgPro20 can prevent infection in people with multiple myeloma (MM) who have hypogammaglobulinemia from receiving bispecific monoclonal antibodies (BsAbs).
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New flu vaccine with booster additive enters human trials
Vaccine Recruiting nowThis clinical trial adopts a seamless design of phase I/II, conducted in two stages: phase I and phase II. Phase I is the age/dose ramp up stage, and phase II is the dose expansion stage.The purpose of this clinical trial is to evaluate the safety and tolerability of different do…
Phase 1/2 • Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
New pill aims to tackle obesity and diabetes by calming inflammation
Disease control CompletedA Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
Phase 2 • Sponsor: NodThera Limited • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a common diabetes drug ease stomach troubles in rare MODY?
Disease control Recruiting nowThe reason for this research study is to better understand the use of liraglutide, a commonly prescribed Type 2 diabetes medication, in patients with a diagnosis of maturity-onset diabetes of the young (MODY). The investigators are interested in better understanding the way that…
Phase 2 • Sponsor: Mansa • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug cocktail aims to protect kidneys in High-Risk patients
Disease control OngoingA Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants with Chronic Kidney Disease and High Proteinuria
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New tracheostomy tube holder aims to cut infections and boost comfort
Symptom relief CompletedThis study evaluated a novel tracheostomy tube fixation device in post-tracheostomy patients with oral cancer. After tracheostomy, conventional fixation methods may be associated with skin pressure injury, wound contamination, frequent dressing changes, tube displacement, and pat…
Sponsor: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New Two-Part cancer drug enters first human tests
Disease control Recruiting nowThe primary objectives of this study are to evaluate the safety and tolerability of TGW101 and determine the recommended dosing regimen(s) for further study. The secondary objectives are to assess pharmacokinetics and preliminary antitumor activity.
Phase 1 • Sponsor: Tagworks Pharmaceuticals BV • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Common diabetes drug may shield kidneys from chemo damage
Disease control Recruiting nowPatients with cancer who receive platinum-based chemotherapy are at increased risk of kidney injury caused by these drugs. This form of toxicity can lead to treatment delays, dose reductions, or permanent discontinuation of chemotherapy, all of which can negatively impact cancer …
Phase 2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a tiny zap save your sight? new device trial for dry AMD
Disease control Recruiting nowThe goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to advanced nonexudative AMD. Participants will: * Undergo an initial loading regimen, followed by 7 m…
Sponsor: i-Lumen Scientific AUS PTY LTD • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC